| Sep 16, 2026 | Ryan Lynch | SEE REMARKS | SELL | 240.000 | $17.90 | $4K |
| Sep 16, 2026 | Jan Pinkas | CHIEF SCIENTIFIC OFFICER | SELL | 658.000 | $17.90 | $12K |
| Sep 16, 2026 | Ellie Im | CHIEF MEDICAL OFFICER | SELL | 623.000 | $17.90 | $11K |
| Sep 16, 2026 | Richard William Scalzo | CHIEF FINANCIAL OFFICER | SELL | 568.000 | $17.90 | $10K |
| Sep 16, 2026 | Barbara Bispham Hale | SEE REMARKS | SELL | 620.000 | $17.90 | $11K |
| Sep 16, 2026 | Joshua T Brumm | CHIEF EXECUTIVE OFFICER | SELL | 9.447K | $16.91 | $160K |
| Sep 16, 2026 | Jonathan McNeill | PRESIDENT AND COO | SELL | 4.570K | $16.90 | $77K |
| Jul 16, 2026 | Fairmount Funds Management LLC, Fairmount Healthcare Fund II LP, Tomas Kiselak, Evan Peter Harwin | DIRECTOR | BUY | 853.450K | $14.50 | $12.4M |
| Jun 22, 2026 | Ryan Lynch | SEE REMARKS | SELL | 465.000 | $17.99 | $8K |
| Jun 22, 2026 | Jan Pinkas | CHIEF SCIENTIFIC OFFICER | SELL | 1.288K | $17.99 | $23K |
| Jun 22, 2026 | Richard William Scalzo | CHIEF FINANCIAL OFFICER | SELL | 1.112K | $17.99 | $20K |
| Jun 22, 2026 | Barbara Bispham | SEE REMARKS | SELL | 1.218K | $17.99 | $22K |
| Jun 22, 2026 | Ellie Im | CHIEF MEDICAL OFFICER | SELL | 1.219K | $17.99 | $22K |
| Jun 22, 2026 | Jonathan McNeill | PRESIDENT AND COO | SELL | 20.549K | $17.99 | $370K |
| Jun 22, 2026 | Joshua T Brumm | CHIEF EXECUTIVE OFFICER | SELL | 42.305K | $17.99 | $761K |
